CA Patent

CA3152988A1 — Oxytocin compositions for treatment of tinnitus

Assigned to Maskbegone LLC · Expires 2021-03-04 · 5y expired

What this patent protects

Provided are methods and compositions for treatment of tinnitus. The method comprises administration of therapeutically effective amount of oxytocin, which may be present with a thickener, and may be delivered to the back of the nasal cavity in a suitable form. Compositions of ox…

USPTO Abstract

Provided are methods and compositions for treatment of tinnitus. The method comprises administration of therapeutically effective amount of oxytocin, which may be present with a thickener, and may be delivered to the back of the nasal cavity in a suitable form. Compositions of oxytocin for intranasal delivery and sprayable unit compositions of oxytocin are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
CA3152988A1
Jurisdiction
CA
Classification
—
Expires
2021-03-04
Drug substance claim
No
Drug product claim
No
Assignee
Maskbegone LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.